Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval.
作者信息
Syed Yahiya Y
机构信息
Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand.
出版信息
Drugs. 2023 Nov;83(16):1543. doi: 10.1007/s40265-023-01965-7.
Abstract
摘要
相似文献
1
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval.更正：0.25%氯虫苯甲酰胺眼用溶液：首次批准。
Drugs. 2023 Nov;83(16):1543. doi: 10.1007/s40265-023-01965-7.
2
Lotilaner Ophthalmic Solution 0.25%: First Approval.Lotilaner 眼科溶液 0.25%：首次批准。
Drugs. 2023 Nov;83(16):1537-1541. doi: 10.1007/s40265-023-01947-9.
3
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).Lotilaner 眼科溶液 0.25%用于治疗蠕形螨睑缘炎：随机、对照、多中心、3 期临床试验（Saturn-2）。
Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5.
4
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial.Lotilaner 眼科溶液 0.25%治疗蠕形螨感染性睑缘炎的安全性和有效性：一项随机、对照、双盲临床试验。
Cont Lens Anterior Eye. 2022 Aug;45(4):101492. doi: 10.1016/j.clae.2021.101492. Epub 2021 Jul 28.
5
Treatment of Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle.睑缘炎治疗：一项比较局部应用 0.25%托拉菌素滴眼液与赋形剂的前瞻性、随机、对照、双盲临床试验。
Ocul Immunol Inflamm. 2023 Oct;31(8):1653-1661. doi: 10.1080/09273948.2022.2093755. Epub 2022 Aug 1.
6
Collarette Elimination and Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25.应用 0.25% 托拉菌素滴眼液进行颈圈消除和螨类根除。
J Ocul Pharmacol Ther. 2021 Oct;37(8):479-484. doi: 10.1089/jop.2021.0011. Epub 2021 Aug 20.
7
Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Blepharitis: A Pilot Study.0.25%洛替拉奈局部用滴眼液治疗睑缘炎的安全性和有效性：一项初步研究
J Ophthalmol. 2021 Sep 21;2021:3862684. doi: 10.1155/2021/3862684. eCollection 2021.
8
Assessment of the speed of flea kill of lotilaner (Credelio™) throughout the month following oral administration to dogs.评估口服洛匹那韦（Credelio™）后整个月内跳蚤杀灭速度。
Parasit Vectors. 2017 Nov 1;10(1):529. doi: 10.1186/s13071-017-2466-0.
9
A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe.一项在欧洲开展的评估 lotilaner（Credelio™）控制犬 ticks 的有效性和安全性的随机、对照研究。
Parasit Vectors. 2017 Nov 1;10(1):531. doi: 10.1186/s13071-017-2478-9.
10
The novel isoxazoline ectoparasiticide lotilaner (Credelio™): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls).新型异噁唑啉类杀虫剂氯氟醚菊酯（立克命）：一种非竞争性昆虫 GABA 门控氯离子通道（GABACls）拮抗剂。
Parasit Vectors. 2017 Nov 1;10(1):530. doi: 10.1186/s13071-017-2470-4.
引用本文的文献
1
Recalcitrant Dry Eye Disease in a 31-Year-Old Female: Favorable Outcomes Following Complete Ocular Lavage Facilitated by an Irrigating Eyelid Retractor.一名31岁女性的顽固性干眼疾病：使用冲洗式眼睑牵开器进行彻底眼部冲洗后的良好效果
Cureus. 2025 Feb 5;17(2):e78554. doi: 10.7759/cureus.78554. eCollection 2025 Feb.
2
A Systematic Review and Meta-Analysis of the Safety and Efficacy of 0.25% Lotilaner Ophthalmic Solution in the Treatment of Demodex Blepharitis.0.25%氯菊酯滴眼液治疗睑缘蠕形螨性睑缘炎安全性和有效性的系统评价与Meta分析
Cureus. 2024 Jan 21;16(1):e52664. doi: 10.7759/cureus.52664. eCollection 2024 Jan.
Zotero 插件